The company is substantially improved its development of a innovative treatment for ATTR-CM, leveraging the investigational drug. Preliminary trial information suggests significant benefits for those diagnosed from the https://attr-cm866826.full-design.com/bridgebio-advances-attr-cm-management-through-the-drug-84772288